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A 5 year old male neutered Cairn Terrier was evaluated for signs of polyuria and polydipsia. Initial hematology and
chemistry panels were unremarkable and urinalysis showed a persistent hyposthenuria. Eleven days later, the dog
became lethargic, inappetent and had developed acute renal failure. The dog was ultimately euthanized due to a
poor response to treatment. Microscopic agglutination titres were consistent with a diagnosis of leptospirosis. The
initial hyposthenuria in this case was consistent with acquired nephrogenic diabetes insipidus. This is an uncommon
presentation of leptospirosis that has not previously been described to progress to acute renal failure. Leptospirosis
should be considered as a differential diagnosis in any dog presenting with polyuria and polydipsia and these patients
should be treated as a zoonotic risk.Background
Leptospirosis is a zoonotic disease caused by infection
with pathogenic Leptospira spp. [1]. Clinical signs associ-
ated with leptospirosis can range from mild non-specific
illness to severe disease associated with kidney, liver and
lung injury. Polyuria and polydipsia are common find-
ings in patients with leptospirosis [1]. The majority of in-
fected dogs with polyuria and/or polydipsia are azotemic
and the polyuria can be attributed to acute tubular injury,
however up to 25% of dogs with dilute urine are not azo-
temic [2]. Some of these polydipsic, non-azotemic patients
could have a decrease in renal function sufficient to impair
concentrating ability without causing azotemia [3]. How-
ever, there is also evidence from experimental animal
models that leptospires may cause a form of acquired
nephrogenic diabetes insipidus (NDI) by making the col-
lecting ducts resistant to the effects of vasopressin [4].
The patient in this report initially presented with signs
compatible with acquired NDI that later progressed to
acute renal failure (ARF). Although the latter syndrome is
well-described, the former is only sporadically docu-
mented and the progression from NDI to ARF has not
been previously described [3,5].* Correspondence: jetish@vsecvet.com
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A five year old male neutered cairn terrier was presented
to the primary veterinarian for an acute onset of leth-
argy, vomiting, and inappetence. The dog had no travel
history outside of Pennsylvania and was vaccinated as
per American Animal Hospital Association recommen-
dations, not including vaccination for leptospirosis [6]. A
complete blood count (CBC) and serum biochemistry
panel were performed with the significant abnormality
being mild thrombocytopenia (Table 1). The dog was
treated supportively with 20 ml/kg lactated Ringer’s
solutiona subcutaneously. The dog’s clinical signs contin-
ued and it was presented to Veterinary Specialty and
Emergency Center (VSEC) on day four. A physical
examination revealed mild dehydration estimated at 5%
without other abnormalities. An electrolyte panel was
performed, revealing mild hypokalemia (Table 1). An ab-
dominal ultrasound showed mild thickening of the gas-
tric body and diffuse hyperechoic mucosal speckling of
the small intestines. The patient was given supportive
care for non-specific gastroenteritis with dolasetronb
(0.5 mg/kg intravenously [IV] q 24 h), famotidinec (0.5
mg/kg IV q 24 h), metronidazoled (10 mg/kg IV q 12 h),
mirtazapinee (7.5 mg per os [PO] q 24 h), and IV lac-
tated Ringer’s solution at a rate of 4 ml/kg. The dog was
discharged to the owner on day five with no further
vomiting and an improved appetite. Treatment was con-
tinued at home with maropitant citratef (2.4 mg/kg PO q
24 h × 4 days), metronidazoleg (12.5 mg/kg PO q 12 h ×d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Pertinent CBC and biochemistry findings
Day 1 Reference range for
day 1
Day 4 Day 24 Day 29 Day 31 Reference range for
days 4, 24, 29, 31
Albumin (g/L) 32 23-40 33 27-44
Alkaline phosphatase (U/L) 166 23-212 173 133 5-131
Alanine aminotransferase (U/L) 29 10-100 55 27 12-118
Blood urea nitrogen (mmol/L) 2.5 2.5-9.6 2.86 19.6 23.6 2.1-11
Creatinine (μmol/L) 106.1 44.2-159.1 79.6 406.6 627.6 44.2-141.4
Glucose (mmol/L) 5.2 4.1-7.9 6.6 6.2 3.9-7.7
Cholesterol (mmol/L) 7.9 2.9-8.3 8. 9 2.4-8.4
Globulin (g/L) 42 25-45 40 16-36
Total bilirubin (μmol/L) 5.1 0-15.4 3.4 1.7-5.1
Phosphorous (mmol/L) 1.3 0.8-2.2 0.7 2.8 0.8-2.2
Potassium (mmol/L) 3.9 3.5-5.8 3.2 3.2 3.1 3.6-5.5
Sodium (mmol/L) 147 144-160 148 142 139 139-154
Chloride (mmol/L) 111 109-122 99 100 99 102-120
Hematocrit (Proportion of 1.0) 0.47 0.37-0.55 0.41 0.36-0.60
White blood cells (× 109/L) 6.84 5.5-16.9 14.2 4.0-15.5
Neutrophils (× 109/L) 5.96 2-12 10.79 2.06-10.6
Bands (× 109/L) 0 0-0.3
Eosinophils (× 109/L) 0.05 0.1-1.49 0.142 0-1.200
Lymphocytes (× 109/L) 0.34 0.5-4.9 2.27 0.69-4.50
Platelets (× 109/L) 139 175-500 160 170-400
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mirtazapine (0.75 mg/kg PO q 24 h as needed for inap-
petance), and the patient was placed on a hydrolyzed
dieti.
On day 24, the dog was presented to VSEC for re-
evaluation after the owner noted an increased thirst and
inappropriate urination in the house since day 18, without
hematuria, stranguria, or pollakiuria. There was no recur-
rence of the gastrointestinal signs and the dog’s appetite
remained good. Physical examination was unremarkable.
A CBC showed persistent mild thrombocytopenia. A
serum biochemistry panel showed mild increases in alka-
line phosphatase, cholesterol and globulins, mild hypokal-
emia, and other non-specific abnormalities as shown in
Table 1. Urine was hyposthenuric (urine specific gravity
[USG] 1.002) with trace protein on urine dipstick (Table 2)
and an unremarkable urine sediment. A urine culture was
submitted to rule out an occult urinary tract infection.
Given the history, marked hyposthenuria, and absence
of azotemia and hyperglycemia, psychogenic (primary)
polydipsia, polydipsia secondary to gastrointestinal dis-
ease, and diabetes insipidus were amongst the primary
differentials [7]. Polydipsia secondary to gastrointestinal
disease was considered unlikely given the lack of reso-
lution with treatment of the gastrointestinal signs [7].
Renal insufficiency was excluded at that time based onthe presence of hyposthenuria, suggesting active dilution
of the urine [8]. The owner was asked to collect a series
of at-home urine samples from the dog over the follow-
ing week to evaluate for evidence of any spontaneous
concentrating ability that would support a diagnosis of
psychogenic polydipsia.
The dog was re-evaluated on day 29. The polyuria had
persisted but the dog was now lethargic, inappetent, was
intermittently vomiting, and had had a significantly re-
duced thirst over the past 5 days. On physical examin-
ation, tacky mucous membranes and decreased skin
turgor were noted; based on these findings and a de-
crease in weight from 9.5 kg to 8.6 kg, the dog was esti-
mated to be 10% dehydrated. No other new physical
examination findings were noted. A serum biochemistry
panel revealed moderate azotemia (Table 1). Urine spe-
cific gravity was 1.006 on a urinalysis with 2+ protein
and 3+ blood (Table 2). Abdominal ultrasound revealed
mild to moderate bilateral renomegaly (left kidney mea-
sured 5.8 cm in craniocaudal dimension versus 5.3 cm
on day 4; right - 6.1 cm versus 4.8 cm). The kidneys had
a rounded, swollen appearance with increased echogeni-
city of the medullae. The liver was also mildly enlarged
and diffusely hypoechoic. The ultrasonographic changes
to the gastrointestinal tract persisted, but were im-
proved compared to day 4. Resting cortisol was 6.1 μg/dL,
Table 2 Urinalysis results
Day 24 Day 26 Day 28 Day 29 Normal reference range
Urine specific gravity 1.002 1.006 1.004 1.006 1.015-1.050
pH 7.0 6.0 5.5-7.0
Protein Trace Negative Negative
Glucose Negative Negative Negative
Ketone Negative Negative Negative
Bilirubin Negative Negative Negative to 1+
Blood Negative 3+ Negative
WBC Negative 2-3 0-3/HPFa
RBCS Negative 0-1 0-3/HPF
Casts None None
Crystals None None
Bacteria None None None
Transitional cells None 0-3 0-1/HPF
Squamous cells None 0-1 0-3/HPF
aHPF = High power field.
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urine protein: creatinine ratio was 4.5. The urine culture
from day 24 showed no bacterial growth. Serum was sub-
mitted for microscopic agglutination test (MAT) against a
panel of seven leptospiral serogroups.
The patient was admitted to the hospital, and treat-
ment with IV lactated Ringer’s solution, ampicillinj (20
mg/kg IV q 8 hr), doxycyclinek (10 mg/kg IV q 24 hr),
dolasetron (0.5 mg/kg IV q 24 hr), and famotidine (0.5
mg/kg IV q 24 hr) was initiated. An indwelling urinary
catheter was placed to measure urine output and to pro-
tect hospital staff and clients against exposure to poten-
tially infectious leptospires in the urine. On day 31, the
dog had a decline in urine output (from 3.1 ml/kg/hr on
day 30 to 1.8 mls/kg/hr on day 31) and developed hyper-
tension (200 mmHg systolic measured by noninvasive
doppler). The azotemia had significantly worsened (Table 1).
The urine output did not increase after boluses of furose-
midel (1 mg/kg IV) and mannitolm (0.5 g/kg IV twice) and
the owners elected to have the dog euthanized. The MAT
results were received after the dog was euthanized and
showed high titres against multiple serovars (Table 3).Table 3 Microscopic agglutination test results
Leptospirosis species and serovar Titer value
L. interrrogans serovar Pomona Positive 1:3200
L. interrrogans serovar Icterohaemorrhagia Negative </=1:50
L. interrrogans serovar Canicola Negative </=1:50
L. kirschneri serovar Grippotyphosa Positive >1:6400
L. interrrogans serovar Hardjo Negative </=1:50
L. interrrogans serovar Autumnalis Positive 1:6400
L. interrrogans serovar Bratislava Positive 1:3200Given the clinical signs and absence of vaccination against
leptospirosis, the markedly elevated MAT in this case was
considered to confirm a diagnosis of leptospirosis [1,10].
Since multiple serovars had a titre >1:3200, the causative
serovar could not be determined.
Discussion
The progression of leptospirosis in this case did not fol-
low the typical pattern that is expected in this disease
[3]. The initial polyuria and polydipsia were accompan-
ied by hyposthenuria and normal biochemical parame-
ters. Although leptospirosis has been reported to cause
isosthenuria or hyposthenuria without azotemia, the au-
thors of these previous studies did not report whether
these cases progressed to more severe signs of renal in-
jury [2,5,11]. Typically, renal insufficiency is considered
less likely if the urine specific gravity is less than 1.006
[8]. However, hyposthenuric urine can be present in
renal failure but suggests the presence of another disease
process that is leading to the hyposthenuria – in this
case this may have been the presence of leptospires in
the renal tubules [12].
Causes of polyuria and polydipsia can be categorized
as primary polydipsia, osmotic diuresis, central diabetes
insipidus (CDI), congenital NDI or acquired NDI. Ac-
quired NDI can be caused by various conditions such as
hypoadrenocorticism, hyperadrenocorticism, pyometra,
pyelonephritis and hypercalcemia which may impair
urinary concentrating ability [8]. In this patient, there
was no evidence of an osmotic diuresis; CDI was consid-
ered unlikely since serum sodium was normal in the face
of significant dehydration; and primary polydipsia was
considered unlikely since there was no evidence of any
concentrating ability after a significant decrease in water
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water intake should have corrected for any medullary
washout, exceeding the number of days recommended
during a water deprivation test [8]. Other causes of ac-
quired NDI were considered unlikely based on presenting
complaints and signalment (e.g. hyperadrenocorticism) or
excluded based on diagnostic findings (e.g. hypoadreno-
corticism, hypercalcemia, urinary tract infection). As a re-
sult, the authors consider the initial polydipsia in this case
to be consistent with acquired nephrogenic diabetes insi-
pidus due to decreased responsiveness of the collecting
ducts to vasopressin in the presence of leptospirosis [4].
Though this dog may have responded to more aggressive
treatment, such as continued fluid therapy guided by
measurement of central venous pressures or performing
dialysis, the owners elected for euthanasia and declined a
post-mortem examination. Although a post-mortem exami-
nation was not performed, markedly elevated MAT titres
against several leptospiral serogroups in an unvaccinated
patient are highly indicative of acute infection with Leptos-
pira. In addition, this patient had a persistent mild
thrombocytopenia, which increases the suspicion for the
diagnosis of leptospirosis in an azotemic patient [3].
Leptospirosis is a well-established zoonotic disease [3].
Transmission to humans usually occurs from chronic
carrier states rather than from incidental hosts that de-
velop acute leptospirosis [13,14]. Leptospires have been
shown to be present in urine prior to the initiation of
proper treatment and in the first two to three days of
treatment in rodent models [15]. It has been recom-
mended that appropriate protective precautions should
be taken in all dogs with acute renal failure until lepto-
spirosis is excluded or an alternate diagnosis is reached
[3]. Although it is possible that the initial clinical signs
of gastritis and inappetence in this patient were caused
by an unrelated disease, they may have been due to early
leptospirosis [2,16,17]. Since leptospires are shed in the
urine within 7-10 days after infection, it is therefore very
likely that this patient was shedding organisms on day
24 when first evaluated for polyuria and polydipsia [3].
Appropriate precautions to protect against the zoonotic
potential of leptospirosis were not taken at this time. In
fact, the owners were instructed to collect urine samples
at home, which could have exposed them to infectious
organisms. The authors would recommend that the
same handling precautions that are taken with the urine
of patients with acute renal failure are also followed in
patients with polyuria and polydipsia until an alternate
final diagnosis is reached.
Conclusion
Leptospirosis should be considered a differential diagno-
sis in any patient presented with polyuria and/or poly-
dipsia without another apparent underlying cause. Thesepatients should be monitored closely for progression to
azotemia and should be treated as a zoonotic risk. Given
the potential for progression to acute renal failure, the
authors recommend routine screening for leptospirosis
before undertaking procedures such as a water depriva-
tion test that may place the patient at additional risk for
renal injury [8]. In conclusion, this case presents evi-
dence that leptospirosis can cause acquired NDI and can
progress to ARF in some patients.
Endnotes
aLactated Ringer’s solution; Abbott Laboratories, North
Chicago, IL.
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dMetronidazole; Hospira, Inc., Lake Forest, IL.
e Remeron; Aurolife Pharma, LLC, Dayton NJ.
fCerenia; Pfizer Animal Health, New York, NY.
gMetronidazole; Teva Pharmaceuticals USA, Inc.,
Sellersville, PA.
hFamotidine; Wockhardt Limited, Mumbai, India.
iRoyal Canin HP diet; Royal Canin USA, Inc, St
Charles MO.
jAmpicillin; Sagent Pharmaceuticals Inc., Schaumburg, IL.
kDoxycycline; APP Pharmaceuticals, LLC., Schaumburg, IL.
lSalix; Intervet, Inc., Millsboro, DE.
mMannitol; Nova-Tech, Inc., Grand Island, NE.
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